[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Nuformix Plc LSE:NFX London Ordinary Share GB00BYW79Y38 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.025 -2.13% 1.15 1.10 1.20 1.175 1.15 1.15 2,120,075 15:56:38
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Nonequity Investment Instruments 0.2 -1.4 -0.2 - 7

Nuformix Share Discussion Threads

Showing 7451 to 7474 of 7750 messages
Chat Pages: 310  309  308  307  306  305  304  303  302  301  300  299  Older
DateSubjectAuthorDiscuss
30/3/2021
18:31
CPI .https://www.uk-cpi.com/markets/pharmaceuticals
georgeo1
30/3/2021
15:51
https://twitter.com/DbVelar/status/1373997206240428032?s=20
georgeo1
30/3/2021
13:19
One failure. Good news for Nuformix &Oxilio. https://pulmonaryfibrosisnews.com/2021/03/16/galactic-1-ipf-trial-gb0139-stopping-high-dose-limiting-low-dose-group/
georgeo1
30/3/2021
08:39
Any news on licensing could send the share price upwards it's a matter of time. Probably sorting out right now with Oxilio partnership.
georgeo1
30/3/2021
08:26
A million dumped straight off the mark. Hope that's not one of our newer investors.
for fx sake
29/3/2021
14:27
https://pharmaphorum.com/news/redx-shares-soar-after-ipf-drug-deal-with-astrazeneca/NFX IPF product inhaler big demand once on the market.jmo.
georgeo1
29/3/2021
10:55
So ...there's undisclosed amount being received here. Might be more than the placing amount.
georgeo1
29/3/2021
10:40
The Placing is conditional upon approval by shareholders of the passing of certain resolutions to be proposed at a general meeting of the Company to be held on 29 March 2021 (the "General Meeting")...pursue additional business development opportunities for NXP001 in oncology should Oxilio not exercise the option to license NXP001 in oncology. Oxilio have already done this , does that mean it's still on.
georgeo1
29/3/2021
09:20
Latest news ...results from AGM all duly passed. Whoop whoop lol.
georgeo1
26/3/2021
10:09
There is a small chance of a boost this afternoon if they get their Innovate grant.
for fx sake
26/3/2021
09:25
Am afraid it's back to 2p here, nice while it lasted , lots of shares to spread around now.
jotoha2
25/3/2021
21:46
See if NFX makes any gains on Friday towards Mondays agenda. Should be interesting to watch this space.
georgeo1
25/3/2021
07:04
See page 17 of the brokers note for a timeline of NXP002
soupdragon55
25/3/2021
00:58
Might hear some progress on NXP002 last news was last October.
georgeo1
24/3/2021
22:12
https://youtu.be/u3_tknVV728Only 2 months in the job and making great positive results. background from big pharmas well known in the respiratory field. Way forward now and shareholder value.
georgeo1
24/3/2021
13:30
Well done Richard, very perceptive.
soupdragon55
24/3/2021
13:22
If it does still not a bad amount issued. With news out prob after announcement. Oxilio moving ahead.
georgeo1
24/3/2021
13:18
Placing coming
richardp19
24/3/2021
11:00
Sorry just I've received ballot for proposals today.
georgeo1
24/3/2021
10:49
On Monday, not today
soupdragon55
24/3/2021
10:11
GM today get your votes in.
georgeo1
24/3/2021
00:08
Quotient ran the previous pharmacokinetic trials on NXP001 for NFX. In essence, NFX don't make anything themselves, they do the academic and research lab work, then outsource to have the drugs made and tested.
soupdragon55
23/3/2021
23:41
What's the deal with NXP001 so far with this lot..https://www.quotientsciences.com/news/quotient-clinical-signs-agreement-with-nuformix-to/
georgeo1
23/3/2021
22:58
Pipeline IPF drugs from FibroGen, Galapagos and PureTech could also generate sales if approved during the COVID recovery period, the analysts said.For kidney disease AstraZeneca, FibroGen, GlaxoSmithKline, Novartis and Travere could see sales increase.
georgeo1
Chat Pages: 310  309  308  307  306  305  304  303  302  301  300  299  Older
ADVFN Advertorial
Your Recent History
LSE
NFX
Nuformix
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211016 16:03:25